Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients
Venerdì 8 gennaio 2021
circa 1 minuti di lettura
Journal and Affiliations:
European Journal of Nuclear Medicine and Molecular Imaging, 8 gennaio 2021
Luca Giovanella, Medicina nucleare e centro tiroide, Istituto di imaging della Svizzera italiana, EOC, Bellinzona
Tags:
131-radioiodine therapy
differentiated thyroid carcinoma
rhTSH
stimulated-thyroglobulin
Authors:
Luca Giovanella